{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:46:08Z","timestamp":1789159568955,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100024856","name":"Agricultural Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jchromb.2025.124576","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T03:46:22Z","timestamp":1743219982000},"page":"124576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["A novel ultra-sensitive LC-MS\/MS method for determination of elobixibat in human plasma; Application to a bioequivalence study on healthy volunteers"],"prefix":"10.1016","volume":"1257","author":[{"given":"Mamdouh R.","family":"Rezk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda","family":"Shawky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal A.","family":"Badr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Wadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2025.124576_bb0005","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.dld.2013.03.016","article-title":"Chronic constipation: a critical review","volume":"45","author":"Basilisco","year":"2013","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jchromb.2025.124576_bb0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1590\/s0004-2803.202200001-23","article-title":"Diagnosis and Management of Chronic Idiopathic Constipation: a narrative review from a Brazilian expert task force","volume":"59","author":"Passos","year":"2022","journal-title":"Arq. Gastroenterol."},{"key":"10.1016\/j.jchromb.2025.124576_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110835","article-title":"ASBT(SLC10A2): a promising target for treatment of diseases and drug discovery","volume":"132","author":"Yang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jchromb.2025.124576_bb0020","first-page":"831","article-title":"Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis, the lancet","volume":"4","author":"Luthra","year":"2019","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.jchromb.2025.124576_bb0025","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/j.gastro.2023.03.214","article-title":"American Gastroenterological Association-American College of Gastroenterology clinical practice guideline: pharmacological management of chronic idiopathic constipation","volume":"164","author":"Chang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jchromb.2025.124576_bb0030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00535-017-1383-5","article-title":"Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial","volume":"53","author":"Nakajima","year":"2018","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jchromb.2025.124576_bb0035","first-page":"537","article-title":"Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial, the lancet","volume":"3","author":"Nakajima","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.jchromb.2025.124576_bb0040","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13571","article-title":"Efficacy, long-term safety, and impact on quality of life of elobixibat in more severe constipation: post hoc analyses of two phase 3 trials in Japan","volume":"31","author":"Nakajima","year":"2019","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.jchromb.2025.124576_bb0045","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1002\/jssc.202200322","article-title":"Development of stability indicating reversed-phase high-performance liquid chromatography method for determination of elobixibat in pure form and laboratory prepared tablets: application to dissolution study","volume":"45","author":"Elagamy","year":"2022","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jchromb.2025.124576_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.aca.2009.10.004","article-title":"A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation","volume":"656","author":"Novakova","year":"2009","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2025.124576_bb0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jpba.2015.05.006","article-title":"Development of a sensitive UPLC-ESI-MS\/MS method for quantification of sofosbuvir and its metabolite, GS-331007, in human plasma: application to a bioequivalence study","volume":"114","author":"Rezk","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2025.124576_bb0060","doi-asserted-by":"crossref","DOI":"10.1007\/s10895-024-04020-0","article-title":"A novel spectrofluorimetric method for vibegron in the newly FDA approved pharmaceutical formulation and in human plasma: analytical QbD strategy for method development and optimization","author":"Wadie","year":"2024","journal-title":"J. Fluoresc."},{"key":"10.1016\/j.jchromb.2025.124576_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2023.109753","article-title":"A novel eco-friendly HPLC method with dual detection modes for versatile quantification of dutasteride and silodosin in pharmaceutical formulation, dissolution testing and spiked human plasma","volume":"197","author":"Wadie","year":"2024","journal-title":"Microchem. J."},{"key":"10.1016\/j.jchromb.2025.124576_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2023.123650","article-title":"State-of-the-art mathematically induced filtration approaches for smart spectrophotometric assessment of silodosin and solifenacin mixture in their new challenging formulation: multi-tool greenness and whiteness evaluation","volume":"307","author":"Rostom","year":"2024","journal-title":"Spectrochim. Acta A"},{"key":"10.1016\/j.jchromb.2025.124576_bb0075","article-title":"Sustainable and smart HPTLC determination of silodosin and solifenacin using a constructed two illumination source chamber with a smartphone camera as a detector: comparative study with conventional densitometric scanner","volume":"33","author":"Wadie","year":"2023","journal-title":"Sustain. Chem. Pharm."},{"key":"10.1016\/j.jchromb.2025.124576_bb0080","doi-asserted-by":"crossref","first-page":"11642","DOI":"10.1039\/D3RA01211E","article-title":"A novel smartphone HPTLC assaying platform versus traditional densitometric method for simultaneous quantification of alfuzosin and solifenacin in their dosage forms as well as monitoring content uniformity and drug residues on the manufacturing equipment","volume":"13","author":"Wadie","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.jchromb.2025.124576_bb0085","article-title":"Electro-polymerized poly-methyldopa as a novel synthetic mussel-inspired molecularly imprinted polymeric sensor for darifenacin: computational and experimental study","volume":"29","author":"Wadie","year":"2022","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.jchromb.2025.124576_bb0090","article-title":"An integrated paradigm between green analytical chemistry and quality-by-design for robust analysis of alcaftadine and ketorolac tromethamine in aqueous humor via sustainable chromatographic methods","volume":"42","author":"Hussein","year":"2024","journal-title":"Sustain. Chem. Pharm."},{"key":"10.1016\/j.jchromb.2025.124576_bb0095","article-title":"A green and versatile HPLC-DAD method for determination of silodosin and solifenacin in their newly combined formulation: evaluation of content uniformity and dissolution profiles","volume":"44","author":"Wadie","year":"2025","journal-title":"Sustain. Chem. Pharm."},{"key":"10.1016\/j.jchromb.2025.124576_bb0100","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1039\/D0AY00822B","article-title":"A novel HPLC-DAD method for simultaneous determination of alfuzosin and solifenacin along with their official impurities induced via a stress stability study; investigation of their degradation kinetics","volume":"12","author":"Tantawy","year":"2020","journal-title":"Anal. Methods"},{"key":"10.1016\/j.jchromb.2025.124576_bb0105","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s00216-013-7542-5","article-title":"LC-MS\/MS in the routine clinical laboratory: has its time come?","volume":"406","author":"Leung","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2025.124576_bb0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ddr.20173","article-title":"Historical review of sample preparation for chromatographic bioanalysis: pros and cons","volume":"68","author":"Chang","year":"2007","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jchromb.2025.124576_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115165","article-title":"LC-MS\/MS-based metabolite quantitation of the antiviral prodrug baloxavir marboxil, a new therapy for acute uncomplicated influenza, in human plasma: application to a human pharmacokinetic study","volume":"223","author":"Gouda","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2025.124576_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123363","article-title":"A validated LC-MS\/MS method for determination of antiviral prodrug molnupiravir in human plasma and its application for a pharmacokinetic modeling study in healthy Egyptian volunteers","volume":"1206","author":"Gouda","year":"2022","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2025.124576_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpba.2014.05.005","article-title":"Development, optimization and validation of a highly sensitive UPLC-ESI-MS\/MS method for simultaneous quantification of amlodipine, benazeprile and benazeprilat in human plasma: application to a bioequivalence study","volume":"98","author":"Rezk","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2025.124576_bb0130","article-title":"Quantification of amlodipine and atorvastatin in human plasma by UPLC\u2013MS\/MS method and its application to a bioequivalence study","volume":"32","author":"Rezk","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2025.124576_bb0135","article-title":"Determination of amlodipine, indapamide and perindopril in human plasma by a novel LC\u2013MS\/MS method: application to a bioequivalence study","volume":"35","author":"Rezk","year":"2021","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2025.124576_bb0140","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/bmc.3690","article-title":"Novel and sensitive UPLC\u2013MS\/MS method for quantification of sofosbuvir in human plasma: application to a bioequivalence study","volume":"30","author":"Rezk","year":"2016","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2025.124576_bb0145","article-title":"Novel determination of sofosbuvir and velpatasvir in human plasma by UPLC-MS\/MS method: application to a bioequivalence study","volume":"32","author":"Rezk","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2025.124576_bb0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchromb.2014.12.002","article-title":"Multi-residues determination of antimicrobials in fish tissues by HPLC\u2013ESI-MS\/MS method","volume":"978-979","author":"Rezk","year":"2015","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2025.124576_bb0155","series-title":"Mass Spectrometry for the Clinical Laboratory","first-page":"37","article-title":"Chapter 3 - sample preparation techniques for mass spectrometry in the clinical laboratory","author":"Stone","year":"2017"},{"key":"10.1016\/j.jchromb.2025.124576_bb0160","article-title":"M10 bioanalytical method validation and study sample analysis","author":"Food and Drug Administration (FDA)","year":"2022","journal-title":"Guidance for industry"},{"key":"10.1016\/j.jchromb.2025.124576_bb0165","series-title":"Biomedical Product Development: Bench to Bedside","first-page":"99","article-title":"Principles of good clinical practice","author":"Foroughi-Heravani","year":"2020"},{"key":"10.1016\/j.jchromb.2025.124576_bb0170","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.4155\/bio-2023-0150","article-title":"Good clinical practices in the bioanalytical laboratory","volume":"15","author":"Tudan","year":"2023","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2025.124576_bb0175","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1111\/bcp.13698","article-title":"Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: a randomized controlled trial","volume":"84","author":"Kumagai","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2025.124576_bb0180","author":"Chemaxon"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322500128X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322500128X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:11:22Z","timestamp":1762553482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157002322500128X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":36,"alternative-id":["S157002322500128X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124576","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel ultra-sensitive LC-MS\/MS method for determination of elobixibat in human plasma; Application to a bioequivalence study on healthy volunteers","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124576","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124576"}}